Evidence map›Paper›PMID 40425645›Full record

ArticleScientific reports2025

Machine learning-driven imaging data for early prediction of lung toxicity in breast cancer radiotherapy.

Tamás Ungvári, Döme Szabó, András Győrfi, Zsófia Dankovics, Balázs Kiss, Judit Olajos, Károly Tőkési

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tamás UngváriMarkusovszky University Teaching Hospital, Markusovszky str. 5, Szombathely, 9700, Hungary. ungvari.tamas@markusovszky.hu.
Döme SzabóMarkusovszky University Teaching Hospital, Markusovszky str. 5, Szombathely, 9700, Hungary.
András GyőrfiMiskolci SZC Bláthy Ottó Villamosipari Technikum, Soltész Nagy Kálmán str 7, Miskolc, 3527, Hungary.
Zsófia DankovicsMarkusovszky University Teaching Hospital, Markusovszky str. 5, Szombathely, 9700, Hungary.
Balázs KissMarkusovszky University Teaching Hospital, Markusovszky str. 5, Szombathely, 9700, Hungary.
Judit OlajosJósa András University Teaching Hospital, Szent István str. 68, Nyíregyháza, 4400, Hungary.
Károly TőkésiHUN-REN Institute for Nuclear Research, Bem square 18/c, Debrecen, 4026, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One possible adverse effect of breast irradiation is the development of pulmonary fibrosis. The aim of this study was to determine whether planning CT scans can predict which patients are more likely to develop lung lesions after treatment. A retrospective analysis of 242 patient records was performed using different machine learning models. These models showed a remarkable correlation between the occurrence of fibrosis and the hounsfield units of lungs in CT data. Three different classification methods (Tree, Kernel-based, k-Nearest Neighbors) showed predictive values above 60%. The human predictive factor (HPF), a mathematical predictive model, further strengthened the association between lung hounsfield unit (HU) metrics and radiation-induced lung injury (RILI). These approaches optimize radiation treatment plans to preserve lung health. Machine learning models and HPF can also provide effective diagnostic and therapeutic support for other diseases.

Indexed as

Breast NeoplasmsLungMachine LearningPulmonary FibrosisRadiation InjuriesAdultAgedFemaleHumansMiddle AgedRetrospective StudiesTomography, X-Ray ComputedArtificial intelligenceBreast cancerCT imageLung injuryMachine learningRadiotherapy

Identifiers

PMID40425645
PMCPMC12117034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.